129 related articles for article (PubMed ID: 3008929)
1. MPTP causes a non-reversible depression of synaptic transmission in mouse neostriatal brain slice.
Wilson JA; Wilson JS; Weight FF
Brain Res; 1986 Mar; 368(2):357-60. PubMed ID: 3008929
[TBL] [Abstract][Full Text] [Related]
2. MPDP+ causes a non-reversible decrease in neostriatal synaptic transmission in mouse brain slice.
Wilson JA; Wilson JS; Weight FF
Brain Res; 1987 Nov; 425(2):376-9. PubMed ID: 2827846
[TBL] [Abstract][Full Text] [Related]
3. MPTP, MPDP+ and MPP+ cause decreases in dopamine content in mouse brain slices.
Wilson JA; Doyle TJ; Lau YS
Neurosci Lett; 1990 Jan; 108(1-2):213-8. PubMed ID: 2304632
[TBL] [Abstract][Full Text] [Related]
4. Actions of MPTP and MPP+ on synaptic transmission in guinea-pig hippocampal slices.
Galvan M; Kupsch A; ten Bruggencate G
Exp Neurol; 1987 May; 96(2):289-98. PubMed ID: 3032664
[TBL] [Abstract][Full Text] [Related]
5. The action of MPTP on synaptic transmission is affected by changes in Ca2+ concentrations.
Wilson JA; Lau YS; Gleeson JG; Wilson JS
Brain Res; 1991 Feb; 541(2):342-6. PubMed ID: 1647250
[TBL] [Abstract][Full Text] [Related]
6. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium.
Vyas I; Heikkila RE; Nicklas WJ
J Neurochem; 1986 May; 46(5):1501-7. PubMed ID: 3485701
[TBL] [Abstract][Full Text] [Related]
7. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Sirinathsinghji DJ; Heavens RP; McBride CS
Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
[TBL] [Abstract][Full Text] [Related]
8. Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport.
Mayer RA; Kindt MV; Heikkila RE
J Neurochem; 1986 Oct; 47(4):1073-9. PubMed ID: 3489072
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tyrosine hydroxylation in rat striatal tissue slices by 1-methyl-4-phenylpyridinium ion.
Hirata Y; Nagatsu T
Neurosci Lett; 1985 Jun; 57(3):301-5. PubMed ID: 3929190
[TBL] [Abstract][Full Text] [Related]
10. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
Perry TL; Yong VW; Jones K; Wall RA; Clavier RM; Foulks JG; Wright JM
Neurosci Lett; 1985 Aug; 58(3):321-6. PubMed ID: 3876525
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine.
Fuller RW; Hemrick-Luecke SK; Robertson DW
Biochem Pharmacol; 1988 Sep; 37(17):3343-7. PubMed ID: 3135812
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
Kindt MV; Heikkila RE; Nicklas WJ
J Pharmacol Exp Ther; 1987 Sep; 242(3):858-63. PubMed ID: 3498818
[TBL] [Abstract][Full Text] [Related]
13. 4-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP+ concentrations and neurotoxicity.
Irwin I; Langston JW; DeLanney LE
Life Sci; 1987 Feb; 40(8):731-40. PubMed ID: 3492652
[TBL] [Abstract][Full Text] [Related]
14. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
Bradbury AJ; Costall B; Domeney AM; Jenner P; Kelly ME; Marsden CD; Naylor RJ
Nature; 1986 Jan 2-8; 319(6048):56-7. PubMed ID: 3484542
[TBL] [Abstract][Full Text] [Related]
15. Neuropharmacological manipulations with MPTP.
Barnes NJ; Bradbury AJ; Costall B; Domeney AM; Kelly ME; Naylor RJ
J Neural Transm Suppl; 1986; 20():47-63. PubMed ID: 3091761
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on striatal biopterin in BALB/c mice.
Lee EH
Neurosci Lett; 1988 Jun; 88(3):297-302. PubMed ID: 3260360
[TBL] [Abstract][Full Text] [Related]
17. Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+.
Ransom BR; Kunis DM; Irwin I; Langston JW
Neurosci Lett; 1987 Apr; 75(3):323-8. PubMed ID: 3495754
[TBL] [Abstract][Full Text] [Related]
18. MPTP, MPP+ and mitochondrial function.
Nicklas WJ; Youngster SK; Kindt MV; Heikkila RE
Life Sci; 1987 Feb; 40(8):721-9. PubMed ID: 3100899
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the tyrosine hydroxylase system by MPTP, 1-methyl-4-phenylpyridinium ion (MPP+) and the structurally related compounds in vitro and in vivo.
Nagatsu T; Hirata Y
Eur Neurol; 1987; 26 Suppl 1():11-5. PubMed ID: 2884110
[TBL] [Abstract][Full Text] [Related]
20. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain.
Mizuno Y; Sone N; Saitoh T
J Neurochem; 1987 Jun; 48(6):1787-93. PubMed ID: 3106573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
